Association between the findings of metachronous secondary primary malignancies and the number of Lugol-voiding lesions.


Journal

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
ISSN: 1442-2050
Titre abrégé: Dis Esophagus
Pays: United States
ID NLM: 8809160

Informations de publication

Date de publication:
04 Sep 2020
Historique:
received: 03 02 2019
accepted: 21 12 2019
revised: 18 10 2019
pubmed: 14 2 2020
medline: 29 7 2021
entrez: 14 2 2020
Statut: ppublish

Résumé

This study was designed to evaluate the relation between dysplastic squamous epithelium in the esophageal mucosa and the development of metachronous secondary primary malignancies (mSPM) other than esophagus after endoscopic resection (ER) in patients with early esophageal squamous cell carcinoma (SCC). We studied 330 patients with early esophageal SCC who underwent ER as a post hoc analysis of a prospective multicenter cohort study (UMIN Clinical Trials Registry ID UMIN000001676). Lugol-voiding lesions (LVL) were graded into 3 categories (A = no lesion; B = 1 to 9 lesions; C ≥ 10 lesions). The following variables were studied: (i) the incidences of mSPM other than esophagus; (ii) the standardized incidence ratios (SIRs) of mSPM; (iii) the cumulative incidence and total number of mSPM other than esophagus; and (iv) predictors of mSPM other than esophagus on analysis with a multivariate Cox proportional-hazards model. After a median follow-up of 46.6 months, mSPM other than esophagus was diagnosed in a total of 73 patients (90 lesions). Among the 106 patients in group C, 37 patients had mSPM (51 lesions), including head and neck cancer in 14 patients (24 lesions) and gastric cancer in 12 patients (16 lesions). The SIR of mSPM was 3.61 in this study subjects. An increase in the LVL grade (A to B to C) was associated with a progressive increase in the cumulative incidence rate of mSPM other than esophagus (P = 0.017 for A vs. C, P = 0.023 for B vs. C). An increase in the LVL grade (A to B to C) was also associated with a progressive increase in the total number of mSPM other than esophagus per 100 person-years (primary events, relative risk [RR] = 1.66 and 3.24 for grades B and C, respectively, vs. A, P = 0.002 for trend; all events, RR = 1.81 and 4.66 for grades B and C, respectively, vs. A, P < 0.0001 for trend). LVL grade C was a strong predictor of mSPM other than esophagus (RR = 3.41 for A vs. C). LVL grade may be a useful predictor of the risk of mSPM other than esophagus after ER in patients with early esophageal SCC.

Identifiants

pubmed: 32052025
pii: 5734967
doi: 10.1093/dote/doz110
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Chikatoshi Katada (C)

Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.

Tetsuji Yokoyama (T)

Department of Health Promotion, National Institute of Public Health, Wako, Japan.

Tomonori Yano (T)

Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Kashiwa, Japan.

Ichiro Oda (I)

Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.

Yuichi Shimizu (Y)

Department of Gastroenterology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

Kenichi Takemura (K)

Department of Gastroenterology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan.

Tomoyuki Koike (T)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Kohei Takizawa (K)

Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.

Motohiro Hirao (M)

Department of Surgery, National Hospital Organization, Osaka National Hospital, Osaka, Japan.

Hiroyuki Okada (H)

Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Norisuke Nakayama (N)

Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.

Yutaro Kubota (Y)

Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.

Yasumasa Matsuo (Y)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.

Hirofumi Kawakubo (H)

Department of Endoscopy Center, Kawasaki Municipal Kawasaki Hospital, Kawasaki, Japan.

Hideki Ishikawa (H)

Department of Molecular-Targeting Cancer Prevention, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Akira Yokoyama (A)

Clinical Research Unit, National Hospital Organization Kurihama Medical and Addiction Center, Yokosuka, Japan.

Manabu Muto (M)

Department of Clinical Oncology, Kyoto University Hospital, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH